Engineering of Large Diameter Vessels

Principles of Regenerative Medicine

Volumn , Issue , 2008, Pages 978-999

  Yazdani, Saami K ^a   Christ, George J ^b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949655214     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369410-2.50059-0     Document Type: Chapter

References (98)

1. National Kidney Foundation NKF-DOQI clinical practice guidelines for hemodialysis adequacy. Am. J. Kidney Dis. 2000, 37:S7-S64.
2. National Kidney Foundation NKF-DOQI clinical practice guidelines for vascular access, 2000. Am. J. Kidney Dis. 2001, 37:S137-S181.
3. National Kidney Foundation Annual report, end stage renal disease clinical performance measures project. Am. J. Kidney Dis. 2002, 42:S1-S96.
4. Aird C. Endothelial cell heterogeneity and atherosclerosis. Curr. Atheroscler. Rep. 2006, 8:69-75.
5. Amiel G.E., Komua M., Shapira O., Yoo J.J., Yazdani S., Berry J., Kaushal S., Bischoff J., Atala A., Soker S. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng. 2006, 12:1-11.
6. Amiel G.E., Komua M., Shapira O., Yoo J.J., Yazdani S., Berry J., Kaushal S., Bischoff J., Atala A., Soker S. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng. 2006, 12:1-11.
7. Badylak S.F., Lantz G.C., Coffey A., Geddes L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J. Surg. Res. 1989, 47:74-80.
8. Baguneid M., Murray D., Salacinski H.J., Fuller B., Hamilton G., Walker M., Seifalian A.M. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol. Appl. Biochem. 2004, 39:151-157.
9. Bank A.J., Wilson R.F., Kubo S.H., Holte J.E., Dresing T.J., Wang H. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. Circ. Res. 1995, 77:1008-1116.
10. Barra J.G., Armentano R.L., Levenson J., Fischer E.I., Pichel R.H., Simon A. Assessment of smooth muscle contribution to descending thoracic aortic elastic mechanics in conscious dogs. Circ. Res. 1993, 73:1040-1050.
11. Barron V., Lyons E., Stenson-Cox C., McHugh P.E., Pandit A. Bioreactor for cardiovascular cell and tissue growth: a review. Ann. Biomed. Eng. 2003, 31:1017-1030.
12. Basaran O., Karakayali H., Emiroglu R., Belli S., Haberal M. Complications and long-term follow-up of 4416 vascular access procedures. Transplant. Proc. 2003, 35:2578-2579.
13. Bergland J.D., Mohseni M.M., Nerem R.M., Sambanis A. A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials 2003, 24:1241-1254.
14. Birkmeyer J.D., Siewers A.E., Finlayson V.A., Stukel T.A., Lucas F.L., Batista I., Welch G., Wennberg D.E. Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 2002, 346:1128-1137.
15. Borschel G.H., Huang Y.C., Calve S., Arruda E.M., Lynch J.B., Down D.E., Kuzon W.M., Dennis R.G., Brown .L. Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng. 2005, 11:778-786.
16. Boulpaep E.L. Arteries and veins. Medical Physiology 2003, 447-462. Saunders, NY. E.L. Boulpaep, W.F. Boron (Eds.).
17. Braddon L.G., Karoyli D., Harrison D.G., Nerem R.M. Maintenance of a functional endothelial cell monolayer on a fibroblast/polymer substrate under physiologically relevant shear stress conditions. Tissue Eng. 2002, 8:695-708.
18. Brink P.R., Ricotta J., Christ G.J. Biophysical characteristics of gap junctions in vascular wall cells: implications for vascular biology and disease. Braz. J. Med.. Biol. Res. 2000, 33:415-422.
19. Campbell J.H., Efendy J.L., Campbell G.R. Novel vascular graft grown within recipient's own peritoneal cavity. Circ. Res. 1999, 85:1173-1178.
20. Cho S.W., Park H.J., Ryu J.H., Kim S.H., Kim Y.H., Choi C.Y., Lee M.J., Kim J.S., Jang I.S., Kim D.I., Kim B.S. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 2005, 26:1915-1924.
21. Christ G., Wingard C. Calcium sensitization as a pharmacological target in vascular smooth muscle regulation. Curr. Opin. Invest. Drug 2005, 6:920-933.
22. Christ G.J., Barr L. Neural control of smooth muscle. A View of Smooth Muscle 2000, 345-395. JAI Press, Greenwich, CT. L. Barr, G.J. Christ (Eds.).
23. Christ G.J., Spray D.C., el-Sabban M., Moore L.K., Brink P.R. Gap junctions in vascular tissues. Evaluating the role of intracellular communication in the modulation of vasomotor tone. Circ. Res. 1996, 79:631-646.
24. Christ G.J., Wang H.Z., Venkateswarlu K., Zhao W., Day N.S. Ion channels and gap junctions: their role in erectile physiology, dysfunction, and future therapy. Mol. Urol. 1999, 3:61-73.
25. Cines D.B., Pollk E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
26. Collins A.J., Kasiske B., Herzog C., Chen S.C., Everson S., Constantini E., Grimm R., McBean M., Xue J., Chavers B. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am. J. Kidney Dis. 2003, 42:A5-A7.
27. Collins A.J., Li S., Gilbertson D.T., Liu J., Chen S.C., Herzog C.A. Chronic kidney disease and cardiovascular disease in the medicare population. Kidney Int. Suppl. 2003, 87:S24-S31.
28. del Valle-Rodriguez A., Calderon E., Ruiz M., Ordonez A., Lopez-Barneo J., Urena J. Metabotropic Ca2+channel-induced Ca2+release and ATP-dependent facilitation of arterial myocyte contraction. PCNS 2006, 103:4316-4321.
29. Deutsch M., Meinhart J., Fischlein T., Preiss P., Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999, 847-855.
30. Gabouev A.I., Schulthesiss D., Mertsching H., Koppe M., Schlote N., Wefer J., Jonas U., Stief C.G. In vitro construction of urinary bladder wall using porcine primary cells reseeded on acellularized bladder matrix and small intestinal submucosa. Int. J. Artif. Organs 2003, 26:935-942.
31. Gilbertson D.T., Liu J., Xue J.L., Louis T.A., Solid C.A., Ebben J.P., Collins A.J. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J. Am. Soc. Nephrol. 2005, 16:3736-3741.
32. Haddock R.E., Hill C.E. Rhythmicity in arterial smooth muscle. J. Physiol. 2005, 566:645-656.
33. Haefliger J.A., Nicod P., Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc. Res. 2004, 62:345-356.
34. Hibino N., Shin'oka T., Matsumura G., Ikada Y., Kurosawa H. The tissue-engineered vascular graft using bone marrow without culture. J. Thorac. Cardiovasc. Surg. 2005, 129:1064-1070.
35. Hoerstrup S.P., Zund G., Sodian R., Schnell A.M., Grunenfelder J., Turina M.I. Tissue engineering of small caliber vascular grafts. Eur. J. Cardiothorac. Surg. 2001, 20:164-169.
36. Hoerstrup S.P., Cummings I.G., Lachat M., Schoen F.J., Jenni R., Leschka S., Neuenschwander S., Schmidt D., Mol A., Gunter C., Gossi M., Genoni M., Zund G. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006, 4:I159-I166.
37. Hsu C.Y., Vittinghoff E., Lin F., Shlipak M.G. The incidence of end-stage renal disease is increasing faster that the prevalence of chronic renal insufficiency. Ann. Intern. Med.. 2004, 141:95-101.
38. Huber T.S., Carter J.W., Carter R.L., Seeger J.M. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J. Vasc. Surg. 2003, 38:1005-1011.
39. Huber T.S., Hirneise C.M., Lee W.A., Flynn T.C., Seeger J.M. Outcome after autogenous brachial-axillary translocated superficial femoropopliteal vein hemodialysis access. J. Vasc. Surg. 2004, 40:311-318.
40. Huynh T., Abraham G., Murray J., Brockbank K., Hagen P.O., Sullivan S. Remodeling of an acellular graft into a physiologically responsive neovessel. Nat. Biotechnol. 1999, 17:1083-1086.
41. Isenberg B.C., Williams C., Tranquillo .T. Small-diameter artificial arteries engineered in vitro. Circ.Res. 2006, 98:25-35.
42. Jarajapu Y., Knot H. Relative contribution of rho kinase and protein kinase C to myogenic tone in rat cerebral arteries in hypertension. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:1917-1922.
43. Jeong S.I., Kwon J.H., Lim J.I., Cho S.W., Jung Y., Kim S.H., Kim Y.H., Lee Y.M., Kim B.S., Choi C.Y., Kim S.J. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 2005, 26:1405-1411.
44. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., Rabkin E., Moran A.M., Schoen F.J., Atala A., Soker S., Bischoff J., Mayer J.E., Kohler T.R. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med.. 2001, 7:1035-1040.
45. Kohler T.R., Kirkman T.R. Dialysis access failure: a sheep model of rapid stenosis. J. Vasc. Surg. 1999, 30:744-751.
46. Kuecherer H.F., Just A., Kirchheim H. Evaluation of aortic compliance in humans. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:1411-1413.
47. Kurpinski K., Park J., Thakar R.G., Li S. Regulation of vascular smooth muscle cells and mesenchymal stem cells by mechanical strain. Mol. Cell Biomech. 2006, 3:21-34.
48. Laflamme K., Roberge C.J., Labonte J., Pouliot S., D'Orleans-Juste P., Auger F.A., Germain L. Tissue-engineered human vascular media with a functional endothelin system. Circulation 2005, 111:459-464.
49. Laflamme K., Roberge C.J., Pouliot S., D'Orleans-Juste P., Auger F.A., Germain L. Tissue-engineered human vascular media produced in vitro by the self-assembly approach present functional properties similar to those of their native bloo. Tissue Eng. 2006, 12:2275-2281.
50. Lagaud G., Davies K.P., Venkateswarlu K., Christ G.J. The physiology, pathophysiology and therapeutic potential of gap junctions in smooth muscle. Curr. Drug Targets 2002, 3:427-440.
51. Lagaud G., Karicheti V., Knot H.J., Christ G.J., Laher I. Inhibitors of gap junctions attenuate myogenic tone in cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H2177-H2186.
52. Laube H.R., Duwe J., Rutsch W., Konertz W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J. Thorac. Cardiovasc. Surg. 2000, 120:134-141.
53. Leyh R.G., Wilhelmi M., Rebe P., Ciboutari S., Haverich A., Mertsching H. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects. Ann. Thorac. Surg. 2006, 81:1466-1470.
54. L'Heureux N., Paquet S., Labbe R., Germain L., Auger F.A. A completely biological tissue-engineered human blood vessel. FASEB J. 1998, 12:47-56.
55. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., Chronos N.A., Kyles A.E., Gregory C.R., Hoyt G., Robbins R.C., McAllister T.N. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med.. 2006, 12:361-365.
56. Lichtenberg A., Tudorache I., Cebotari S., Suprunov M., Tudorache G., Goerler H., Park J.K., Hilfiker-Kleiner D., Ringes-Lichtenberg S., Karck M. Preclinical trials of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006, 114:I559-I565.
57. McClellan .M. Epidemic end-stage renal disease in the United States. Artif. Organs 1994, 18:413-415.
58. McCulloch A.D., Harris A.B., Sarraf C.E., Eastwood . New multi-cue bioreactor for tissue engineering of tubular cardiovascular samples under physiological conditions. Tissue Eng. 2004, 10:565-573.
59. McFetridge P.S., Bodamyali T., Horrocks M., Chaudhuri J.B. Endothelial and smooth muscle cell seeding onto processed ex vivo arterial scaffolds using 3D vascular bioreactors. ASAIO J. 2004, 50:591-600.
60. McKee J.A., Banik S.S., Boyer M.J., Hamad N.M., Lawson J.H., Niklason L.E., Counter C.M. Human arteries engineered in vitro. EMBO Rep. 2003, 4:633-638.
61. Michiels C. Endothelial cell functions. J. Cell Physiol. 2003, 196:430-443.
62. Mironov V., Kasyanov V., McAllister K., Oliver S., Sistino J., Markwald R. Perfusion bioreactor for vascular tissue engineering with capacities for longitudinal stretch. J. Craniofac. Surg. 2003, 14:340-347.
63. Moosmang S., Schulla V., Welling A., Feil R., Feil S., Wegener J.W., Hofmann F., Klugbauer N. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J. 2003, 22:6027-6034.
64. Naito Y., Imai Y., Shin'oka T., Kashiwagi J., Aoki M., Watanabe M., Matsumura G., Kosaka Y., Konuma T., Hibino ., Murata A., Miyake T., Kurosawa H. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. J. Thorac. Cardiovasc. Surg. 2003, 125:419-420.
65. Narita Y., Hata K.I., Kagami H., Usui A., Ueda M., Ueda Y. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Eng. 2004, 10:1224-1233.
66. Nasseri B.A., Pomerantseval L., Kaazempur-Mofrad M.R., Sutherland F.W., Perry T., Ochoa E., Thompson C.A., Mayer J.E., Oesterle S.N., Vacanti J.P. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng. 2003, 9:291-299.
67. Nerem R.M. Role of mechanics in vascular tissue engineering. Biorheology 2003, 40:281-287.
68. Neville R.F., Abularrage C.J., White P.W., Sidawy A.N. Venous hypertension associated with arteriovenous hemodialysis access. Semin. Vasc. Surg. 2004, 17:50-56.
69. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., Langer R. Science 1999, 285:489-493.
70. Niklason L.E., Abbott W., Gao J., Klagges B., Ulubayram K., Conroy N., Jones R., Vasanawala A., Sanzgiri S., Langer R. Morphological and mechanical characteristics of engineered bovine arteries. J. Vasc. Surg. 2001, 33:628-638.
71. Opitz F., Schenke-Layland K., Richter W., Martin D.P., Degenkolbe I., Wahlers T., Stock U.A. Tissue engineering of ovine aortic blood vessel substitutes using applied shear stress and enzymatically derived vascular smooth muscle cells. Ann. Biomed. Eng. 2004, 32:212-222.
72. Opitz F., Schenke-Layland K., Cohnert T.U., Halbhuber K.J., Martin D.P., Stock U.A. Tissue engineering of aortic tissue: dire consequence of suboptimal elastic fiber synthesis in vivo. Cardiovasc. Res. 2004, 63:719-730.
73. Poh M., Boyer M., Solan A., Dahl S.L., Pedrotty D., Banik S.S., McKee J.A., Klinger R.Y., Counter C.M., Niklason L.E. Blood vessels engineered from human cells. Lancet 2005, 364:2122-2124.
74. Portner R., Nagel-Heyer S., Goepfert C., Adamietz P., Meenen N.M. Bioreactor design for tissue engineering. J. Biosci. Bioeng. 2005, 100:235-245.
75. Rabkin E., Schoen F.J. Cardiovascular tissue engineering. Cardiovasc. Pathol. 2002, 11:305-317.
76. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med.. 2003, 9:702-712.
77. Ratcliffe A. Tissue engineering of vascular grafts. Matrix Biol. 2000, 19:353-357.
78. Safar M.E., Blacher J., Mourad J.J., London G.M. Stiffness of carotid artery wall material and blood pressure in humans, application to antihypertensive therapy and stroke prevention. Stroke 2000, 31:782-790.
79. Sales K.M., Salacinski H.J., Alobaid N., Mikhail M., Balakrishnan V., Seifalian A.M. Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol. 2005, 23:461-467.
80. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., Sakamoto T., Nagatsu M., Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J. Thorac. Cardiovasc. Surg. 2005, 129:1330-1338.
81. Shirota T., He H., Yasui H., Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng. 2003, 9:127-136.
82. Shum-Tim D., Stock U., Hrkach J., Shin'oka T., Lien J., Moses J., Stamp A., Taylor G., Moran A.M., Landis W., Langer R., Vacanti J.P, Mayer J.E. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac. Surg. 1999, 68:2298-2305.
83. Soletti L., Niepnice A., Guan J., Stankus J.J., Wanger .R., Vorp .A. A seeding device for tissue engineered tubular structures. Biomaterials 2006, 27:4863-4870.
84. Stitzel J., Liu J., Lee S.J., Komua M., Berry J., Soker S., Lim G., Van Dyke M., Czerw R., Yoo J.J., Atala A. Controlled fabrication of a biological vascular substitute. Biomaterials 2006, 27:1008-1094.
85. Teebken O.E., Haverich A. Tissue engineering of small diameter vascular grafts. Eur. J. Endovasc. Surg. 2002, 23:475-485.
86. Teebken O.E., Bader A., Steinhoff G., Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularized porcine matrix. Eur. J. Vasc. Endovasc. Surg. 2000, 19:381-386.
87. Teebken O.E., Pichlmaier A.M., Haverich A. Cell seeded decellularized allogeneic matrix grafts and biodegradable polydioxanone-prostheses compared with arterial autografts in a porcine model. Eur. J. Vasc. Endovasc. Surg. 2001, 22:139-145.
88. Thompson C.A., Colon-Hernandez P., Pomerantseva I., MacNeil B.D., Nasseri B., Vacanti J.P., Oesterle S.N. A novel pulsatile, laminar flow bioreactor for the development of tissue-engineered vascular structures. Tissue Eng. 2002, 8:1083-1088.
89. Tiwari A., Salacinski H.J., Hamilton G., Seifalian A.M. Tissue engineering of vascular bypass grafts: role of endothelial cell extraction. Eur. J. Vasc. Endovasc. Surg. 2001, 21:193-201.
90. Vara D.S., Salacinski H.J., Kanna R.Y., Bordenave L., Hamilton G., Seifalian A.M. Cardiovascular tissue engineering: state of the art. Pathol. Biol. 2005, 53:599-612.
91. Wang H.Z., Day N., Valcic M., Hsieh K., Serels S., Brink P.R., Christ G.J. Intracellular communication in cultured human vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2001, 281:C75-C88.
92. Watanabe M., Shin'oka T., Tohyama S., Hibino N., Konuma T., Matsumura G., Kosaka Y., Ishida T., Imai Y., Yamakawa M., Ikada Y., Morita S. Tissue engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001, 7:429-439.
93. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
94. Williams C., Wick T.M. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng. 2004, 10:930-941.
95. Williams C., Wick T.M. Endothelial cell-smooth muscle cell co-culture in a perfusion bioreactor system. Ann. Biomed. Eng. 2005, 33:920-928.
96. Xu J., Ge H., Zhou X., Yang D., Guo T., He J., Li Q., Hao Z. Tissue-engineered vessel strengthens quickly under physiological deformation: application of a new perfusion bioreactor with machine vision. J. Vasc. Res. 2005, 42:503-508.
97. Yang J., Motlagh D., Webb A.R., Ameer G.A. Novel biphasic elastomeric scaffold for small-diameter blood vessel tissue engineering. Tissue Eng. 2005, 11:1876-1886.
98. Yu H., Dai W., Yang Z., Kirkman P., Weaver F.A., Eton D., Rowe .L. Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene graft in vivo. J. Vasc. Surg. 2003, 38:557-563.